Skip to Content

Stereotactic Radiotherapy Conference

October 19-20, 2013  

The University of Texas MD Anderson Cancer Center
Conference Center – Floor 8, Dan L. Duncan Building (CPB)
1155 Pressler Street, Houston, Texas

General Information 

Goal

This international symposium will focus on providing updated information about the roles of stereotactic radiotherapy including stereotactic radiosurgery and stereotactic body radiation therapy in the management of cancers. Many of the presentations are geared towards cutting-edge technology, updated clinical data/protocols and sources of controversy. The practitioners attending this symposium will obtain current knowledge about indications, techniques, controversies and future research directions using stereotactic radiotherapy. Our symposium is intended to improve practitioner knowledge and performance, clinical management, and research.

Educational Objectives

After attending this conference, participants should be able to

  • Interpret the evolving clinical indications and patient selection criteria for stereotactic radiotherapy (Knowledge, Competence);
  • Illustrate the potential toxicities, particularly severe long-term side effects such as grade 3 and above pneumonitis, hemoptysis, fistulae, chest wall pain, rib fracture, neuropathy and the approaches to minimize them (Knowledge, Competence);
  • Implement the cutting-edge technology used to manage tumor motion and optimize stereotactic radiotherapy design and delivery to improve patient care (Knowledge, Competence, Performance, Patient Outcomes);
  • Explore novel concepts of combining stereotactic radiotherapy with immune and/or molecular target therapy in locally advanced and metastatic cancers (Knowledge, Competence); and
  • Debate about the controversies and discuss ongoing research projects and future research directions (Knowledge).

Target Audience

  • Lectures
  • Question-and-Answer Sessions 
  • Panel Discussions 
  • Posters Case Study 
  • Audience Response System

Evaluation

A course evaluation form will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.

Accreditation/Credit Designation

Physicians: The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 9.50 AMA PRA Category 1 Credits™.  Physicians should claim only credit commensurate with the extent of their participation in the activity.  

Radiologic Technologist Credits: Pending approved by the America Society of Radiologic Technologists (ASRT) for Category A continuing education credit.  Medical Dosimetrist Credits: Pending approval by the Medical Dosimetrist Certification Board (MDCB) for continuing education credit.

CME Certificates and Attendance Verification Certificates

Certificates awarding AMA PRA Category 1 Credits™ or certificates documenting attendance will be distributed to participants when an individual departs the conference.  To obtain a CME certificate, physicians must submit a completed evaluation questionnaire and a CME Verification Form.  Upon request, a record of attendance (certificate) will be provided on-site to other health care professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.


© 2013 The University of Texas MD Anderson Cancer Center